Pharmaceutical regulations in Iraq: from medicine approval to post-marketing

Weight and consequences of post-marketing (-approval) experience.

In the European Union the term pharmacovigilance is normally used to describe post-marketing or, more precisely, post-approval experience after the regulatory approval of drugs and their introduction to the market under defined conditions. The term describes activities used to gather information on the effects of medicinal products, with emphasis on those aspects which have not, or could not ha...

Marketing approval of mogamulizumab

Therapeutic properties of antibodies strongly depend on the composition of their glycans. Most of the currently approved antibodies are produced in mammalian cell lines, which yield mixtures of different glycoforms that are close to those of humans, but not fully identical. Glyco-engineering is being developed as a method to control the composition of carbohydrates and to enhance the pharmacolo...

Sex, gender, and pharmaceutical politics: From drug development to marketing.

BACKGROUND Biological sex differences and sociocultural gender norms affect the provision of health care products and services, but there has been little explicit analysis of the impact of sex differences and gender norms on the regulation of pharmaceutical development and marketing. OBJECTIVES This article provides an overview of the regulation of pharmaceuticals and examines the ways that r...

Separating continuing medical education from pharmaceutical marketing.

Using Predictive Analysis to Optimize Pharmaceutical Marketing

Most businesses have benefited from utilizing advanced analytics for marketing and other decision making. However, to apply analytical techniques for pharmaceutical marketing is challenging and emerging as it is critical to ensure the analysis makes sense from the medical side. Whether the drug for a specific disease finally consumed is directly and indirectly influenced by many factors includi...